Sattva Neelapu Selected Research

Sattva Neelapu Research Topics

Disease

15	Neoplasms (Cancer) 05/2024 - 05/2006
10	B-Cell Lymphoma (Lymphoma, B Cell) 05/2024 - 05/2006
9	Lymphoma (Lymphomas) 09/2023 - 08/2012
8	Hodgkin Disease (Hodgkin's Disease) 01/2020 - 02/2008
6	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2020 - 11/2009
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 12/2013
3	Hematologic Neoplasms (Hematological Malignancy) 02/2024 - 11/2012
3	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 08/2007 - 05/2006
2	Infections 02/2024 - 12/2013
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 01/2021 - 01/2019
2	Neutropenia 01/2018 - 12/2013
2	Thrombocytopenia (Thrombopenia) 01/2018 - 12/2013
2	Anemia 07/2017 - 12/2013
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2013 - 08/2007
1	Invasive Pulmonary Aspergillosis 02/2024
1	Aspergillosis 02/2024
1	Opportunistic Infections (Opportunistic Infection) 02/2024
1	Plasmacytoma 09/2023
1	Cutaneous Lupus Erythematosus 01/2022
1	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2020
1	Body Weight (Weight, Body) 01/2020
1	Adenocarcinoma 01/2020
1	Cytokine Release Syndrome 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Disease Progression 11/2018
1	Second Primary Neoplasms (Neoplasms, Second) 11/2018
1	Central Nervous System Diseases (CNS Diseases) 01/2018
1	Fever (Fevers) 01/2018
1	Hypothyroidism 01/2018
1	Burkitt Lymphoma (Burkitt's Lymphoma) 11/2015
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2015
1	Fatigue 12/2013
1	Dyspnea (Shortness of Breath) 12/2013

Drug/Important Bio-Agent (IBA)

9	Rituximab (Mabthera)FDA Link 01/2023 - 08/2007
7	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 12/2013
6	Cyclophosphamide (Cytoxan)FDA LinkGeneric 02/2024 - 12/2013
5	Vincristine (Oncovin)FDA LinkGeneric 12/2018 - 12/2013
4	Prednisone (Sone)FDA LinkGeneric 12/2018 - 12/2013
3	Chimeric Antigen ReceptorsIBA 05/2024 - 01/2020
3	VaccinesIBA 09/2023 - 05/2006
3	Etoposide (VP 16)FDA LinkGeneric 12/2018 - 05/2015
2	ibrutinibIBA 01/2023 - 11/2018
2	Monoclonal AntibodiesIBA 01/2022 - 02/2007
2	Dacarbazine (DIC)FDA LinkGeneric 01/2020 - 04/2014
2	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2015
2	CytokinesIBA 01/2020 - 12/2013
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020 - 04/2014
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 12/2013
2	Methotrexate (Mexate)FDA LinkGeneric 01/2018 - 12/2013
2	PanobinostatIBA 01/2018 - 12/2013
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018 - 12/2013
2	AntigensIBA 09/2013 - 05/2006
2	Gemcitabine FDA Link 10/2011 - 02/2008
1	RNA (Ribonucleic Acid)IBA 05/2024
1	axicabtagene ciloleucelIBA 05/2024
1	Lenalidomide (CC 5013)FDA Link 01/2023
1	UbiquitinIBA 01/2022
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	pembrolizumabIBA 01/2020
1	venetoclaxIBA 01/2020
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2020
1	acalabrutinibIBA 01/2020
1	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020
1	Ifosfamide FDA LinkGeneric 01/2018
1	Bortezomib (Velcade)FDA Link 01/2018
1	IceIBA 01/2018
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 01/2018
1	Thyroxine (Levothyroxine)FDA LinkGeneric 01/2018
1	Carboplatin (JM8)FDA LinkGeneric 01/2018
1	Texas redIBA 01/2017
1	Dihydrotachysterol (AT 10)IBA 01/2017
1	MelatoninIBA 01/2017
1	MK 2206IBA 11/2015
1	Everolimus FDA Link 12/2013
1	LigandsIBA 09/2013
1	HLA-A*02:01 antigenIBA 09/2013
1	11- (2- pyrrolidin- 1- ylethoxy)- 14,19- dioxa- 5,7,26- triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa- 1(25),2(26),3,5,8,10,12(27),16,21,23- decaeneIBA 11/2012
1	Janus Kinase 2IBA 11/2012
1	coltuximab ravtansineIBA 08/2012
1	Immunoconjugates (Immunoconjugate)IBA 08/2012
1	Histone Deacetylase InhibitorsIBA 12/2011
1	mocetinostatIBA 12/2011
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 10/2011
1	Yttrium-90IBA 11/2009
1	ibritumomab tiuxetan (Zevalin)FDA Link 11/2009
1	denileukin diftitox (Ontak)FDA Link 08/2007
1	Cancer VaccinesIBA 02/2007
1	IpilimumabIBA 02/2007
1	PolyethyleneimineIBA 07/2006

Therapy/Procedure

11	Radiotherapy 01/2021 - 05/2015
8	Therapeutics 01/2022 - 10/2011
6	Drug Therapy (Chemotherapy) 02/2024 - 12/2013
2	Aftercare (After-Treatment) 05/2024 - 12/2013
2	Stem Cell Transplantation 01/2018 - 12/2011
1	Hematopoietic Stem Cell Transplantation 02/2024
1	Drug Tapering 01/2018
1	Combination Drug Therapy (Combination Chemotherapy) 01/2017
1	Immunotherapy 09/2013
1	Intravenous Infusions 08/2012